reports
Teleflex Reports First Quarter Financial Results and Full Year 2024 Ou...
Teleflex Reports First Quarter Financial Results and Full Year 2024 Outlook WAYNE, Pa., May 02, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the first quarter ended March 31, 2024. First quarter financial summary Revenues of $737.8 million, up 3.8% compared to the prior year period; up 3.8% on a constant currency basisGAAP diluted EPS from continuing operations of $0.33, compared to $1.63 in the prior year periodAdjusted diluted EPS from continuing operations of $3.21, compared to $3.09 in the prior year period 2...
Teleflex Announces Multiple Clinical and Real-World Evidence Studies t...
Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting Highlights include two head-to-head randomized clinical trials (RCT) data presentations of UroLift™ System vs. other modalities to treat benign prostatic hyperplasia (BPH) -Additional studies examine post-surgery medication use, rates of hospitalization and adverse events of standard BPH treatments -Teleflex unveils latest advancements in BPH treatment with UroLift™ 2 System with Advanced Tissue Control (ATC) designed to treat all prostate types -...
Teleflex Announces the Limited Market Release of the Wattson™ Temporar...
Teleflex Announces the Limited Market Release of the Wattson™ Temporary Pacing Guidewire Company expands structural heart portfolio and begins the limited market release of a bipolar temporary pacing guidewire intended to introduce and position catheters and other interventional devices within the chambers of the heart while transmitting an electrical signal from an external pulse generator to the heart WAYNE, Pa., April 30, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that the Wattson™ Temporary Pacing Gui...
Teleflex to Present at the BofA Securities 2024 Health Care Conference
Teleflex to Present at the BofA Securities 2024 Health Care Conference WAYNE, Pa., April 30, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the BofA Securities 2024 Health Care Conference at the Encore Hotel in Las Vegas, Nevada, on Tuesday, May 14, 2024, at 2:20 p.m. (PT). A live audio webcast of the conference presentation will be available on the investor section of the Teleflex website at . About Teleflex IncorporatedTeleflex is a global provider of medical technologies designed to improve the health and ...
Teleflex Announces First Quarter 2024 Earnings Conference Call Informa...
Teleflex Announces First Quarter 2024 Earnings Conference Call Information WAYNE, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, May 2, 2024. To participate in the conference call, please utilize this to pre-register and receive the dial-in information. The call can also be accessed through a live audio webcast on the company’s website, . An audio replay of the call will be available beginning at 11:00 am Easte...
Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced T...
Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types WAYNE, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- (NYSE:TFX), a leading global provider of medical technologies, today announced the upcoming full market release of the Advanced Tissue Control (ATC) feature on its unified UroLift™ 2 System platform designed for the treatment of benign prostatic hyperplasia (BPH) symptoms in men with all prostate types up to 100g. The UroLift™ 2 System with Advanced Tissue Control (UroLift™ 2 ATC) has rece...
Teleflex’s Climate Targets Validated by the Science Based Targets Init...
Teleflex’s Climate Targets Validated by the Science Based Targets Initiative Teleflex commits to reach net-zero greenhouse gas emissions across its value chain by 2050. WAYNE, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced its near- and long-term climate change targets have been validated by the Science Based Targets initiative (SBTi). The announcement comes ahead of the company’s release of its 2023 Global Impact Report, which will be published in May 2024. Teleflex has responded to the SBTi...
Teleflex Announces Quarterly Dividend
Teleflex Announces Quarterly Dividend WAYNE, Pa., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable March 15, 2024, to shareholders of record at the close of business on March 1, 2024. Additional information about Teleflex can be obtained from the company’s website at . About Teleflex Incorporated Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. W...
Teleflex Reports Fourth Quarter and Full Year 2023 Financial Results
Teleflex Reports Fourth Quarter and Full Year 2023 Financial Results WAYNE, Pa., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the fourth quarter ended December 31, 2023. Fourth quarter financial summary Revenues of $773.9 million, reflective of five fewer shipping days year-over-year, up 2.1% compared to the prior year period; up 0.7% on a constant currency basis GAAP diluted EPS from continuing operations of $0.66, compared to $1.65 in the prior year period Adjusted diluted EPS from continuing operations of ...
Teleflex to Present at the 45th Annual Raymond James Institutional Inv...
Teleflex to Present at the 45th Annual Raymond James Institutional Investors Conference WAYNE, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 45th Annual Raymond James Institutional Investors Conference at the JW Marriott Orlando Grande Lakes, Orlando, FL, on Tuesday, March 5, 2024, at 1:40 p.m. (ET). A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor section of the Teleflex website at . About Teleflex In...
Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Inform...
Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information WAYNE, Pa., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, February 22, 2024. To participate in the conference call, please utilize this to pre-register and receive the dial-in information. The call can also be accessed through a live audio webcast on the company’s website, . An audio replay of the call will be available beginning at 11:00 am Ea...
Teleflex now offers its Titan SGS™ Stapler with Staple Line Reinforcem...
Teleflex now offers its Titan SGS™ Stapler with Staple Line Reinforcement A New Choice for Bariatric Surgeons: Titan SGS™ Standard Staple Line Reinforcement with GORE® SEAMGUARD® Bioabsorbable Staple Line Reinforcement WAYNE, Pa., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that the Titan SGS™ Stapler—the only purpose-built stapler for gastric tissue with a specific indication for sleeve pouch creation in bariatric procedures1—is now available with staple line reinforcement (SLR). This new option...
Teleflex Awarded Peripheral Access Agreement with Premier, Inc.
Teleflex Awarded Peripheral Access Agreement with Premier, Inc. WAYNE, Pa., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded the Peripheral Access purchasing agreement with Premier, Inc. Effective December 1st, 2023, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Teleflex’s Peripheral Access products. Premier has awarded Teleflex a national multi-source agreement for Peripherally Inserted Central ...
Teleflex Announces First Patient Enrollment in ACCESS-MANTA™ Registry
Teleflex Announces First Patient Enrollment in ACCESS-MANTA™ Registry Registry Intends to Examine Contemporary On-Label Use of the MANTA™ Vascular Closure Device Including Appropriate Patient Selection and Proper Vascular Access WAYNE, Pa., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the first patient enrollment in a clinical registry that is intended to examine and collect data on outcomes of contemporary on-label use of the MANTA™ Vascular Closure Device (VCD) in standard of care transcatheter ...
Large-Scale Real-World Study Demystifies UroLift™ System Durability an...
Large-Scale Real-World Study Demystifies UroLift™ System Durability and Reinforces Superior Patient Experience for Men With Enlarged Prostate Compared to Leading Surgical Treatments WAYNE, Pa., Nov. 14, 2023 (GLOBE NEWSWIRE) -- (NYSE:TFX), a leading global provider of medical technologies, announced today that a new peer-reviewed study in the Nature journal Prostate Cancer and Prostatic Diseases reinforces the position of the UroLift™ System as the gold standard in minimally invasive surgical treatment (MIST) for benign prostatic hyperplasia (BPH), or enlarged prostate. is the largest l...
Teleflex to Present at the 35th Annual Piper Sandler Healthcare Confer...
Teleflex to Present at the 35th Annual Piper Sandler Healthcare Conference WAYNE, Pa., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 35th Annual Piper Sandler Healthcare Conference at The Lotte New York Palace, New York, NY, on Tuesday, November 28, 2023 at 11:30 a.m. (ET). A live audio webcast of the conference presentation will be available on the investor section of the Teleflex website at . About Teleflex IncorporatedTeleflex is a global provider of medical technologies designed to improve t...
Teleflex Announces Quarterly Dividend
Teleflex Announces Quarterly Dividend WAYNE, Pa., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable December 15, 2023, to shareholders of record at the close of business on November 15, 2023. Additional information about Teleflex can be obtained from the company’s website at . About Teleflex Incorporated Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s...
Teleflex Reports Third Quarter Financial Results and Full Year 2023 Ou...
Teleflex Reports Third Quarter Financial Results and Full Year 2023 Outlook WAYNE, Pa., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended October 1, 2023. Third quarter financial summary Revenues of $746.4 million, up 8.7% compared to the prior year period; up 7.4% on a constant currency basisGAAP diluted EPS from continuing operations of $2.91, compared to $2.16 in the prior year periodAdjusted diluted EPS from continuing operations of $3.64, compared to $3.27 in the prior year period 2023 ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.